We previously found that oxygen-glucose-serum deprivation/restoration(OGSD/R) induces apoptosis of spinal cord astrocytes, possibly via caspase-12 and the integrated stress response, which involves protein kinase R-like endoplasmic reticulum kinase(PERK), eukaryotic initiation factor 2-alpha(eIF2α) and activating transcription factor 4(ATF4). We hypothesized that edaravone, a low molecular weight, lipophilic free radical scavenger, would reduce OGSD/R-induced apoptosis of spinal cord astrocytes. To test this, we established primary cultures of rat astrocytes, and exposed them to 8 hours/6 hours of OGSD/R with or without edaravone(0.1, 1, 10, 100 μM) treatment. We found that 100 μM of edaravone significantly suppressed astrocyte apoptosis and inhibited the release of reactive oxygen species. It also inhibited the activation of caspase-12 and caspase-3, and reduced the expression of homologous CCAAT/enhancer binding protein, phosphorylated(p)-PERK, p-eIF2α, and ATF4. These results point to a new use of an established drug in the prevention of OGSD/R-mediated spinal cord astrocyte apoptosis via the integrated stress response. We previously found that oxygen-glucose-serum deprivation / restoration (OGSD / R) induces apoptosis of spinal cord astrocytes, via viapase-12 and the integrated stress response, which involves protein kinase R- like endoplasmic reticulum kinase (PERK) We hypothesized that edaravone, a low molecular weight, lipophilic free radical scavenger, would reduce OGSD / R-induced apoptosis of spinal cord astrocytes. To test this, we established primary cultures of rat astrocytes, and exposed them to 8 hours / 6 hours of OGSD / R with or without edaravone (0.1, 1, 10, 100 μM) treatment. We found that 100 μM of edaravone significantly suppressed astrocyte apoptosis and inhibited the release of reactive oxygen species. It also inhibits the activation of caspase-12 and caspase-3, and reduced the expression of homologous CCAAT / enhancer binding protein, phosphorylated (p) -PERK, p-eIF2α, and ATF4. These results po int to a new use of an established drug in the prevention of OGSD / R-mediated spinal cord astrocyte apoptosis via the integrated stress response.